Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,984 | 2 | 94.6% |
| Food and Beverage | $113.64 | 7 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $1,984 | 2 | $0 (2021) |
| Janssen Biotech, Inc. | $95.63 | 6 | $0 (2024) |
| Galderma Laboratories, L.P. | $18.01 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $77.66 | 4 | Janssen Biotech, Inc. ($77.66) |
| 2023 | $17.97 | 2 | Janssen Biotech, Inc. ($17.97) |
| 2021 | $1,984 | 2 | GENZYME CORPORATION ($1,984) |
| 2019 | $18.01 | 1 | Galderma Laboratories, L.P. ($18.01) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 05/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Immunology | ||||||
| 03/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Immunology | ||||||
| 12/20/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: Immunology | ||||||
| 12/18/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: Immunology | ||||||
| 10/01/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $894.00 | General |
| Category: Immunology | ||||||
| 09/23/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,090.00 | General |
| Category: Immunology | ||||||
| 10/29/2019 | Galderma Laboratories, L.P. | SOOLANTRA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: ROSACEA | ||||||
About Dr. Michael Bradshaw, MD
Dr. Michael Bradshaw, MD is a Surgery healthcare provider based in Grand Junction, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821101031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bradshaw, MD has received a total of $2,098 in payments from pharmaceutical and medical device companies, with $77.66 received in 2024. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($1,984).
Practice Information
- Specialty Surgery
- Location Grand Junction, CO
- Active Since 08/15/2006
- Last Updated 09/13/2012
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1821101031
Products in Payments
- DUPIXENT (Biological) $1,984
- TREMFYA (Drug) $95.63
- SOOLANTRA (Drug) $18.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Grand Junction
Douglas Hirth, Md, MD
Surgery — Payments: $96,366
Steven O'day, Md, MD
Surgery — Payments: $43,605
Alero Nanna, Md, MD
Surgery — Payments: $34,241
James Hanosh, Md, MD
Surgery — Payments: $28,901
Courtney Fulton, M.d, M.D
Surgery — Payments: $17,621
Darren Nisly, Do, DO
Surgery — Payments: $15,453